BioCentury
ARTICLE | Product Development

Pfizer’s MacKenzie: Other diseases deserve the same acceleration as COVID-19: a BioCentury audio interview

Chief development officer calls for sustained pace of regulatory interactions

September 11, 2020 2:42 AM UTC

Pfizer’s Rod MacKenzie says the collaborations and accelerated timelines taking place during COVID-19 are causing introspection in pharmas for how they operate, and for how they can push for regulators to continue the pace of interactions they’re setting during the pandemic into its aftermath.

Pfizer Inc. (NYSE:PFE) administered the first dose of the COVID-19 mRNA vaccine it’s co-developing with BioNTech SE (NASDAQ:BNTX) two hours after FDA approved the trial, MacKenzie, EVP and chief development officer at the pharma, told BioCentury...

BCIQ Company Profiles

Pfizer Inc.